Cecal microbiome transplantation without antibiotic preconditioning standardizes murine
microbiomes.
Finding the right fit: Evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data.
High-resolution differentiation of enteric bacteria in premature infant fecal microbiomes using a novel rRNA amplicon.
Mucosal microbiome in patients
with early bowel polyps: Inferences from short-read and long-read 16S rRNA sequencing.
High-resolution microbiome analysis reveals exclusionary Klebsiella species competition in preterm infants at risk for necrotizing enterocolitis.
High-resolution taxonomic characterization reveals novel
human microbial strains with potential as risk factors and probiotics for prediabetes and type 2 diabetes.
August 2025:
GutID Interview
with Elena Panzeri
Intus Bio Launches GutID™ Microbiome Test, Bringing the Power of Its Breakthrough Titan-1™ Platform to Patients and Consumers
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing
I took a £349 test at home to find out the state of my gut health
Insights from the Microbiome
Do you need a $599 gut test? What your poop can tell you about your health
Dr. Mark Driscoll, co-founder of GutID and Intus Bio, joins hosts Dr. Caitlin Prickett to discuss gut microbiome health by analyzing bacterial diversity and imbalances.